20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway

Nickel nanoparticles (Nano-Ni) are widely utilized in industrial and biomedical applications due to their unique physicochemical properties. However, their expanded usage increases risks of occupational and environmental exposure. In this study, we established a mouse exposure model via single intratracheal instillation of Nano-Ni and analyzed the perturbation characteristics of lung tissue metabolic profiles using untargeted metabolomics. Subsequently, the biological function of the key metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) was explored in Nano-Ni-exposed lung epithelial cells to elucidate the underlying mechanisms of metabolic alterations in Nano-Ni-induced pulmonary fibrosis. Our results showed that exposure to Nano-Ni induced marked alveolar architecture destruction, interstitial thickening, and upregulated expression of fibrotic markers in mouse lung tissues. Metabolomics identified arachidonic acid metabolism as the most disrupted pathway, with 20-HETE exhibiting the most pronounced downregulation. In both BEAS-2B and A549 cell lines, exogenous 20-HETE supplementation significantly attenuated Nano-Ni-induced epithelial-mesenchymal transition (EMT). Furthermore, Nano-Ni exposure reduced mRNA and protein levels of free fatty acid receptor 1 (FFAR1) both in vivo and in vitro. Pretreatment with the FFAR1 agonist GW9508 mitigated Nano-Ni-induced EMT and the activation of NF-κB signaling pathway in both cell lines. Critically, FFAR1 inhibition largely abolished the suppressive effects of 20-HETE on EMT and NF-κB signaling. Altogether, our study suggests that 20-HETE may affect the EMT process in lung epithelial cells at least in part through regulating the FFAR1/NF-κB pathway, thereby potentially contributing to the process of Nano-Ni-induced lung fibrosis. These findings point to a possible role of specific metabolites in Nano-Ni-induced pulmonary fibrosis and may provide novel mechanistic insights into the inhalation toxicity of nanomaterials.

Authors

Institutions

Publication Details

Journal
Chemical Research in Toxicology
Published
2026-06-18
DOI
https://doi.org/10.1021/acs.chemrestox.6c00048
Primary Topic
Eicosanoids and Hypertension Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway

Qunwei Zhang, Yiqun Mo, Zhenyao Huang, Shuai Zhang et al.
Chemical Research in Toxicology
Eicosanoids and Hypertension Pharmacology
article

20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway

Qunwei Zhang, Yiqun Mo, Zhenyao Huang, Shuai Zhang, Zhenyu Yan, Huihui Yang, Jiali Yuan, Jing Li
article en

Abstract

Nickel nanoparticles (Nano-Ni) are widely utilized in industrial and biomedical applications due to their unique physicochemical properties. However, their expanded usage increases risks of occupational and environmental exposure. In this study, we established a mouse exposure model via single intratracheal instillation of Nano-Ni and analyzed the perturbation characteristics of lung tissue metabolic profiles using untargeted metabolomics. Subsequently, the biological function of the key metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) was explored in Nano-Ni-exposed lung epithelial cells to elucidate the underlying mechanisms of metabolic alterations in Nano-Ni-induced pulmonary fibrosis. Our results showed that exposure to Nano-Ni induced marked alveolar architecture destruction, interstitial thickening, and upregulated expression of fibrotic markers in mouse lung tissues. Metabolomics identified arachidonic acid metabolism as the most disrupted pathway, with 20-HETE exhibiting the most pronounced downregulation. In both BEAS-2B and A549 cell lines, exogenous 20-HETE supplementation significantly attenuated Nano-Ni-induced epithelial-mesenchymal transition (EMT). Furthermore, Nano-Ni exposure reduced mRNA and protein levels of free fatty acid receptor 1 (FFAR1) both in vivo and in vitro. Pretreatment with the FFAR1 agonist GW9508 mitigated Nano-Ni-induced EMT and the activation of NF-κB signaling pathway in both cell lines. Critically, FFAR1 inhibition largely abolished the suppressive effects of 20-HETE on EMT and NF-κB signaling. Altogether, our study suggests that 20-HETE may affect the EMT process in lung epithelial cells at least in part through regulating the FFAR1/NF-κB pathway, thereby potentially contributing to the process of Nano-Ni-induced lung fibrosis. These findings point to a possible role of specific metabolites in Nano-Ni-induced pulmonary fibrosis and may provide novel mechanistic insights into the inhalation toxicity of nanomaterials.

Chemical Research in Toxicology
Xuzhou Medical College (CN), Center for Human Genetics (US), Institute of Human Genetics (PL), University of Louisville Hospital (US)
Openalex Percentile: Top 9%
Eicosanoids and Hypertension Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.